17,000+ key IP decision-makers rely on Life Sciences IP Review (LSIPR) as their daily source of news in the life sciences, biotechnology and pharmaceutical industry. LSIPR offers IP professionals a single point of contact to stay on top of industry trends and developments. No other online platform offers such in-depth or comprehensive analysis of the latest IP news in the life sciences. To access our quarterly e-magazine, daily news articles or to learn more about upcoming events, visit our website: www.lifesciencesipreview.com.

Follow us on:

Twitter: https://twitter.com/LifeSciencesIPR
LinkedIn: www.linkedin.com/showcase/life-sciences-ip-review
Facebook: www.facebook.com/LifeSciencesIPReview/